Elena Carrara

ORCID: 0000-0003-1004-515X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotic Use and Resistance
  • Antibiotic Resistance in Bacteria
  • Bacterial Identification and Susceptibility Testing
  • Antibiotics Pharmacokinetics and Efficacy
  • COVID-19 Clinical Research Studies
  • Urinary Tract Infections Management
  • Patient Satisfaction in Healthcare
  • Nosocomial Infections in ICU
  • Pneumonia and Respiratory Infections
  • Neutropenia and Cancer Infections
  • SARS-CoV-2 and COVID-19 Research
  • Electronic Health Records Systems
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Long-Term Effects of COVID-19
  • Blood disorders and treatments
  • Sepsis Diagnosis and Treatment
  • Surgical site infection prevention
  • Health Systems, Economic Evaluations, Quality of Life
  • COVID-19 and healthcare impacts
  • Healthcare cost, quality, practices
  • Zoonotic diseases and public health
  • Liver Disease Diagnosis and Treatment
  • Clostridium difficile and Clostridium perfringens research
  • Medical and Biological Sciences
  • Drug-Induced Hepatotoxicity and Protection

University of Verona
2017-2025

Azienda Ospedaliera Universitaria Integrata Verona
2023

University of Brescia
2021

University Children's Hospital Tübingen
2017-2020

Istituto Zooprofilattico Sperimentale delle Venezie
2020

University of Pavia
2014-2019

Policlinico San Matteo Fondazione
2016-2017

Istituti di Ricovero e Cura a Carattere Scientifico
2016-2017

Hospital Universitario Virgen Macarena
2017

Instituto de Biomedicina de Sevilla
2017

10.1016/s1473-3099(17)30753-3 article EN The Lancet Infectious Diseases 2017-12-21

Pulmonary thrombosis is observed in severe acute respiratory syndrome coronavirus 2 pneumonia. Aim was to investigate whether subpopulations of platelets were programmed procoagulant and inflammatory activities disease 2019 (COVID-19) patients with pneumonia, without comorbidities predisposing thromboembolism. Approach Results: Overall, 37 28 healthy subjects studied. Platelet-leukocyte aggregates, platelet-derived microvesicles, the expression P-selectin, active fibrinogen receptor on...

10.1161/atvbaha.120.315175 article EN other-oa Arteriosclerosis Thrombosis and Vascular Biology 2020-10-14

ObjectiveTo use Multi-Criteria Decision Analysis (MCDA) to determine weights for eleven criteria in order prioritize COVID-19 non-critical patients admission hospital healthcare settings with limited resources.MethodsThe MCDA was applied two main steps: specification of prioritizing (and levels within each criterion); and determination the based on experts' knowledge experience managing patients, via an online survey. Criteria were selected available evidence a focus low- middle-income...

10.1016/j.ijid.2020.06.082 article EN cc-by-nc-nd International Journal of Infectious Diseases 2020-06-30

Healthcare-associated infections (HAI) are among the most common adverse events of medical care. Surveillance HAI is a key component successful infection prevention programmes. Conventional surveillance - manual chart review resource intensive and limited by concerns regarding interrater reliability. This has led to development use automated (AS). Many AS systems product in-house efforts heterogeneous in their design methods. With this roadmap, PRAISE network aims provide guidance on how...

10.1016/j.cmi.2021.02.028 article EN cc-by-nc-nd Clinical Microbiology and Infection 2021-06-30

Abstract Objectives/purpose The costs attributable to antimicrobial resistance (AMR) remain theoretical and largely unspecified. Current figures fail capture the full health economic burden caused by AMR across human, animal, environmental health; historically many studies have considered only direct associated with human infection from a hospital perspective, primarily high-income countries. Global Antimicrobial Resistance Platform for ONE-Burden Estimates (GAP-ON€) network has developed...

10.1186/s13756-020-00822-6 article EN cc-by Antimicrobial Resistance and Infection Control 2020-11-26

There is increasing evidence that psycho-social factors can influence antimicrobial prescribing practice in hospitals and the community, represent potential barriers to stewardship interventions. Clinicians are conditioned both by emotional cognitive based on fear, uncertainty, a set of beliefs, risk perception bias, interpersonal established through social norms peer doctor-patient communication. However, gap emerging between research practice, no recommendation addresses most appropriate...

10.1093/jac/dkz308 article EN Journal of Antimicrobial Chemotherapy 2019-06-28

Healthcare-associated infections (HAI) are a major public health concern. Monitoring of HAI rates, with feedback, is core component infection prevention and control programmes. Digitalization healthcare data has created novel opportunities for automating the surveillance process to varying degrees. However, methods not standardized vary widely between different facilities. Most current automated (AS) systems have been confined local settings, practical guidance on how implement large-scale...

10.1016/j.cmi.2021.02.027 article EN cc-by-nc-nd Clinical Microbiology and Infection 2021-06-30

The increasing burden of candidemia and the emergence resistance, especially among non-Candida albicans strains, represent a new threat for public health. We aimed to assess status surveillance identify publicly accessible resistance data in Candida spp. blood isolates from systems epidemiological studies 28 European 4 Free Trade Association member states.A systematic review national international networks, 2015 2020, peer-reviewed studies, 2005 lasting at least 12 consecutive months with...

10.3390/jof8030249 article EN cc-by Journal of Fungi 2022-02-28

In recent years, there has been an exponential increase in the generation and accessibility of electronic healthcare data, often referred to as “real-world data”. The landscape data sources significantly expanded encompass traditional databases newer such social media, wearables, mobile devices. Advances information technology, along with growth computational power evolution analytical methods relying on bioinformatic tools and/or artificial intelligence techniques, have enhanced potential...

10.3389/fdsfr.2024.1356405 article EN cc-by Frontiers in Drug Safety and Regulation 2024-03-18
Coming Soon ...